budesonide inhalation
budesonide inhalation is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including budesonide inhalation. Available dosage form: suspension.
Drug details
- Generic Name
- budesonide inhalation
- Brand Names
- budesonide inhalation
- Application Number
- ANDA210897
- Sponsor
- A-S Medication Solutions
- NDC Codes
- 3
- Dosage Forms
- SUSPENSION
- Routes
- RESPIRATORY (INHALATION)
- Active Ingredients
- BUDESONIDE
Indications and Usage
1 INDICATIONS AND USAGE Budesonide inhalation suspension is an inhaled corticosteroid indicated for: • Maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age () Limitations of Use: Not indicated for the relief of acute bronchospasm () 1.1 Maintenance Treatment of Asthma Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age. Limitations of Use: • Budesonide inhalation suspension is NOT indicated for the relief of acute bronchospasm.